Lobbying client

MYLAN, INC.

Pharmaceuticals

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 5 of its records are shown together here.

Filings
81
Filed by
5
Reported in-house
—
Reported by firms
$937,500

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2009 to 2021

Filings

8 filings for 2012, newest first.
Filing Filed by Amount
4th Quarter - Report
4th Quarter 2012
MFJ INTERNATIONAL — reported
4th Quarter - Report
4th Quarter 2012
EVERTZ GROUP LLC $30,000 reported
3rd Quarter - Report
3rd Quarter 2012
MFJ INTERNATIONAL — reported
3rd Quarter - Report
3rd Quarter 2012
EVERTZ GROUP LLC $30,000 reported
2nd Quarter - Report
2nd Quarter 2012
MFJ INTERNATIONAL — reported
2nd Quarter - Report
2nd Quarter 2012
EVERTZ GROUP LLC $30,000 reported
1st Quarter - Report
1st Quarter 2012
MFJ INTERNATIONAL — reported
1st Quarter - Report
1st Quarter 2012
EVERTZ GROUP LLC $30,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
EVERTZ GROUP LLC 29 $730,000
FULCRUM PUBLIC AFFAIRS LLC 4 $80,000
THE MADISON GROUP 4 $67,500
MFJ INTERNATIONAL 21 $40,000
LINCOLN POLICY GROUP 14 $20,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 28
Trade (domestic/foreign) TRD 24
Pharmacy PHA 13
Medicare/Medicaid MMM 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.